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Abstract:  
It is estimated that more than 2-4% of hospital admissions are related to drug induced reactions. There is an ever expanding list of 
medications linked to pathologic reactions in the oral and perioral region. Several patterns of diseases have been identified, and 
these can assist the clinician in determining a possible cause and effect relationship with a particular or a group of drugs. The 
mechanism of drug induced reaction is not always known or not always predictable since aspects other than pharmacodynamics 
and/or pharmacokinetics, as well as various interacting variables contribute to the final outcome. Drug induced oral reactions 
clinically present as Xerostomia, Swelling, Dysguesia, Nonspecific Ulceration, Vesiculobullous or ulcerative mucositis, 
pigmentation of mucosa, Gingival enlargement, oral malodor, taste alterations, discoloration of teeth. This review gives an update 
of the various drug induced oral reactions, so that Dentists and oral health professionals increase their knowledge for a better 
diagnosis and therapy. 
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INTRODUCTION: 
Several systemic factors are known to contribute to oral 
diseases or conditions and among those are the intake of 
drugs. An adverse drug reaction is defined by WHO as ‘a 
response to a drug which is noxious and unintended, and 
which occurs at doses normally used in man for the 
prophylaxis, diagnosis, therapy of diseases or for the 
modification of physiological function’. [1]. Fortunately 
several patterns of diseases have been identified and these 
can assist the clinician in determining a possible cause and 
effect relationship with a particular medication or a group of 
medications. The clinical patterns of drug induced oral 
reactions include. Considering the ageing of the population 
and widespread and increased use of presciptions, over the 
counter drugs and herbal remedies, dentists can expect to 
encounter oral side effects among their patients due to the 
usage of these medications. Since many patients take 
prescriptions and nonprescription medications, dentists 
should take a thorough medical history and be aware of 
medication related problems and their potential effects on 
diagnosis and treatment planning [2-4]. 
 
SALIVARY GLAND DISORDERS: 
Salivary gland function can be affected by a variety of drugs 
that can produce xerostomia, ptyalism, Salivary gland pain 
and discolouration of saliva. 
A] XEROSTOMIA: 
Dryness of mouth or Xerostomia, results from diminished 
secretions of saliva and a decrease in salivary calcium 
phosphate concentration. More than 250 medications claim 
xerostomia as a side effect. Few of the drugs are, 
anticholinergics, antidepressants, anti-Parkinson’s drugs, 
antihistamines, antipsychotics, diuretics, hypnotics, systemic 
bronchodilators, muscle relaxants, methyldopa, laxatives, 
betablockers, narcotics, guanabenz, and clonidine. 
Furthermore  the possibility of an underlying autoimmune 
etiology(eg. Sjogren Syndrome) should also be considered in 
Xerostomic patients, especially those who also present with 
Xerophthalmia or evidence of parotid gland swelling. 
Common oral manifestations resulting from decreased 
salivary flow include increased dental caries, fungal 
infections, bacterial infections, aphthous lesions, and 
dysphagia. Pilocarpine and Bethanechol have been suggested 
to be of potential use in the management of drug induced 
Xerostomia [5]. Drugs with potential to cause xerostomia are 
shown in Table 1. 
B] PTYALISM: 
Ptyalism or sialorrhoea , is the condition of increased salivary 
flow, and it is uncommon. Salivary hypersecretion is usually 
caused by physiological factors such as menstruation or early 
pregnancy, local factors such as teething, oral inflammatory 
lesions, food, medication, or by nasogastric intubation.[6]. 
Sialorrhoea is also caused by certain heavy metal toxins 
(mercury and thallium),from exposure to irreversible 
acetylcholinesterase inhibitors (insecticides and nerve agents) 
and by a few other drugs such as yohimbine, mucosa 
irritanting antibiotics.[7]. Drugs causing ptyalism are listed in 
Table 2. 
C] SALIVARY GLAND PAIN: 
Antihypertensives, anti-thyroid agents, chlorhexidine, 
cytotoxics, ganglion-blocking agents, iodides, 
phenothiazines, and sulphonamides may cause salivary gland 
pain, as may drugs causing dry mouth.[8]. Salivary gland 
pain is rarely associated with guanethidine or guanacline. 
Drugs causing salivary gland pain and swelling are listed in 
Table 3 
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Table 2: Drugs Causing Ptyalism.[30,34,43-45]. 
  Alprazolam 
  Ambroxol 
  Amiodarone 
  Bethanechol 
  Buprenorphine 
  Buspirone 
  Clozapine 
  Desfluorane 
  Diazoxide 
  Digoxin 
  Ethoinamide 
  Edrophonium 
  Galantamine 
  Gentamycin 
  Guanethidine 
  Haloperidol 
  Imipenem/cilastatin 
  Iodides  
  Kanamycin 
  Ketamine 
  Lamotrigine 
  Levodopa 
 
  Mefenamic acid 
  Mercurial salts 
  Modafinil 
  Neostigmine 
  Nicardipine 
  Niridazole 
  Nitrazepam 
  Ofanzapine 
  Organophosphates 
  Pentoxifylline 
  Physostigmine 
  Pilocarpine 
  Remoxipride 
  Risperidone 
  Rivestigmine 
  Sildenafil 
Succinylchloride 
  Tacrine 
  Theophylline 
  Tobramycin 
  Venlafaxine 
  Zaleplon 
  Zonisamide 
 
Table 3: Drugs Causing Salivary Gland Swelling and 
Pain.[30,34,43-45]. 
  Bethanidine 
  Bretylium 
  Catecholamine 
inhalation 
  Cimetidine 
  Clonidine 
  Clozapine 
  Deoxycycline 
  Famotidine 
  Guanethidine 
  Iodine 
  Insulin 
  Interferon 
 
  Isoprenaline 
  Methyldopa 
  Naproxen 
  Nifedipine 
  Nitrofurantoin 
  Oxyphenylbutazone 
  Phenylbutazone 
  Phenytoin 
  Ranitidine 
  Ritodrine 
  Sulofonamides 
  Trimepramine 
  Warfarin 
 
D] DISCOLORATION OF SALIVA: 
Discoloration of saliva and other body fluids into red or 
orange colour may be seen in patients treated with 
clofazimine, levodopa, rifampicin, and rifabutin therapy.[9].  
 
ORAL ULCERATION: 
Ulceration is a breach in the oral epithelium, which typically 
exposes nerve endings in the underlying lamina propria, 
resulting in pain or soreness especially when eating spicy 
foods or citrus fruits. Oral Ulcers are Inflammatory lesions of 
the oral mucosa that affect approximately 20% of the 
Table 1: Drugs Causing Xerostomia. [30,34,43-45]. 
  Alizapride 
  Ambroxol 
  Amphetamines 
  Antihistamines 
  Antimigrain agents 
  Antineoplastics 
  Antiparkinson drugs 
  Atropine 
  Benzodiazepines 
  Beta blockers 
  Bladonna alkaloids 
  Botulinum toxin-A 
  Bupropion 
  Cadmium 
  Calcium channel blockers 
  Ciprofloxacin 
  Clidinium 
  Clozapine 
  Cyclobezaprine 
  Cyclopentolate 
  Cyclosporine 
  Cytokines 
  Dexmedetomidine 
  Ephedrine 
  Fenfluramine 
  Gentamycin 
  Glycopyrolate 
  Guanabenz 
  Guanfacine 
  Hyoscine 
  Insulin 
  Ipratropium 
  Isotretinoin 
  Ketanserin 
  Ketotifen 
  L-dopa 
  Lead 
  Lithium 
  Lubiprostone 
  Mazindol 
  Methdilazine 
  Modafinil 
  Molindone 
  Nabilone 
  Nefazodone 
  Nefopam 
  Nicotine 
  Nitric oxide inhibitors 
 
 
  Ofloxacin 
  Olanzapine 
  Ondansetron 
  Opioids 
  Orphenadrine 
  Oxybutynin 
  Paricalcitol 
  Phenothiazines 
  Phenylpropanola
mine 
  Posaconazole 
  Pregabalin 
  Propantheline 
  Proton pump 
inhibitors 
  Radioiodine 
  Reboxetine 
  Selegiline 
  Sertraline 
  Sibutramine 
  Solifenacin 
  Sotalol 
  Spiramycin 
  Sucralfate 
  Tadalafil 
  Tamsulosin 
  Tadalafil 
  Terazosin 
  Terodiline 
  Thiabendazole 
  Thioridazine 
  Tiamenidine 
  Tiapride 
  Tiotropium 
  Tizamidine 
  Tolterodine 
  Tramadol 
  Tranylcypromine 
  Trazodone 
  Trepium chloride 
  Triamterene 
  Trimipramine 
  Tropicamide 
  Trospium 
  Venlafaxine 
  Viloxazine 
  Vigabatrin 
  Zuclopenthixol 
  Zopiclone 
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immunological alterations, infections, nutritional 
deficiencies, repetitive trauma to the mucosa, food and 
contact allergies, autoimmune diseases and neoplasms, as 
well as psychosomatic, genetic and environmental 
factors.[11]. Drugs with potential to cause oral ulceration are 
shown in Table 4. 
 
Table 4: Drugs Causing Oral ulceration. [17,37,46]. 
  Anti HIV drugs 
  Antineoplastics 
  Alendronate 
  Allopurinol 
  Alprazolam 
  Asprin 
  Atrovastatin 
  Aurothiomalate 
  Azathiopurine 
  Aztreonam 
  Barbiturates 
  Captopril 
  Carbamazepine 
  Chlorambucil 
  Chloramphenicol 
  Choloroquine 
  Chlorpromazine 
  Clarithromycin 
  Clofibrate 
  Clonazepam 
  Codeine 
  Cyclosporine 
  Diclofenac 
  Dideoxycytidine 
  Emepromium 
  Enalapril 
  Erythromycin 
  Fluconazole 
  Fluoxetine 
  Ganciclovir 
  Gefitinib 
  Gold Compounds 
  Hydralazine 
  Hydroxyurea 
  Ibuprofen 
  Imatinib 
 
  Imipramine 
  Indomethacin 
  Interferons 
  Interleukin-2 
  Isoprenaline 
  Ketorolac 
  Lamotrigine 
  Levamisole 
  Lithium 
  Losartan  
  Mesalamine 
  Methimazole 
  Methotrexate 
  Metronidazole 
  Mitomycin 
  Naproxen 
  Nicorandil 
  NSAIDs 
  Olanzapines 
  Pancreatin 
  Penicillamine 
  Penicillins 
  Phenylbutazone 
  Phenytoin 
  Potassium chloride 
  Proguanil 
  Promethazine 
  Propranolol 
  Quinidine 
  Streptomycin 
  Sulindac 
  Terbutaline 
  Tetracycline 
  Vancomycin 
  Venlafaxine 
  Warfarin 
 
A].NONSPECIFIC ULCERATION: 
Oral Ulceration may be caused as a result of direct 
application of over the counter drugs like asprin, hydrogen 
peroxide, potassium tablets, and phenol containing 
compounds. The affected mucosa appears whitish and 
corrugated, with erosion and ulceration of the more severely 
damaged areas.[12]. 
B]. APHTHOUS ULCERATION: 
Ulcers resembling recurrent aphthous stomatitis but have 
systemic causes are often termed Aphthous like ulcers. 
Examples include Behcet’s syndrome, gastrointestinal 
diseases, such as gluten-sensitive enteropathy or 
inflammatory bowel disease, immunodeficiency syndromes 
such as infection with HIV, cyclic neutropenia and adverse 
reactions to medications.[13-15]. A number of drug are 
implicated in the development of nonspecific  ulceration and 
oral mucositis, and the lesions are often associated with an 
equally nonspecific histologic appearance at biopsy. These 
include barbiturates, beta-blockers, dapsone, NSAIDs, 
phenazone derivatives, thiazide derivatives, phenolphthalein, 
sulfonamides, tetracyclines, and sirolimus.[16]. Ulceration of 
the mucosa is a common adverse effect of a wide variety of 
antineoplastic agents, including methotrexate, 5-fluoroucil, 
doxorubicin and melphalan. 
C].FIXED DRUG ERUPTIONS: 
Fixed drug eruptions in the oral cavity often initially appear 
as areas of edema and erythema that lead to the localized, 
nonspecific ulceration. The labial mucosa is most commonly 
involved, and a clinical course of recurrence at the same site 
after drug use is diagnostically helpful, but this relationship is 
not always easy to establish. A number of drugs are 
implicated in the development of nonspecific ulceration and 
oral mucositis, and the lesions are often associated with an 
equally nonspecific histologic appearance at biopsy. These 
include barbiturates, beta-blockers, dapsone, NSAIDs, 
phenazone derivatives, thiazide derivatives, phenolphthalein, 
sulfonamides, and tetracyclines.[17]. 
D]. MUCOSITIS: 
Chemotherapy regimens play a vital role in Oral mucositis 
and ulceration, particularly those involving methotrexate, 5-
fluorouracil, doxorubicine, melphelan, mercaptopurine, or 
bleomycin.[18]. Widespread sloughing and ulceration arise 
within days of commencement of therapy, the associated pain 
often requiring opioid therapy and/or alteration or cessation 
of chemotherapy. The ulceration may be a portal of entry for 
infection and hence a potential cause of septicemia. 
E]. PEMPHIGOID LIKE REACTIONS: 
Pemphigoid like reactions can be limited to the oral mucosa, 
or they can affect other mucosal or cutaneous sites. 
Clinically, lesions appear as relatively sturdy vesicles or 
bullae that break down into shallow ulceration. Thiol-
containing drugs and sulfonamide derivatives are among the 
most commonly involved medications, as are the therapeutic 
classes of NSAIDs, cardiovascular agents, antimicrobials, 
and antirheumatics.[19]. The oral mucosa is frequently 
affected in drug induced pemphigoid, particularly 
penicillamine-induced disease, and can be the only affected 
mucosal surface, although patients often also have cutaneous 
lesions. 
F]. PEMPHIGUS: 
Pemphigus like reactions can have features of either 
Pemphigus vulgaris or Pemphigus foliaceous, although 
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Traditionally, drugs that are capable of inducing pemphigus 
are divided into two main groups according to their chemical 
structure—drugs containing a sulfhydryl radical (thiol drugs 
or SH drugs) and non-thiol.[20]. Pemphigus vulgaris may 
occasionally be associated with drugs with active thiol groups 
in the molecule. Drugs implicated include penicillamine, 
phenol drugs , rifampicin, diclofenac , and other ACE-
inhibitors.[21]. 
G]. ERYTHEMA MULTIFORMAE: 
As with idiopathic or virally induced cases(Herpes simplex 
virus), the disease has a rapid onset with a variable 
expression that can range from lesions limited to the oral 
mucosa with widespread mucocutaneous involvement. Drug 
induced EM is frequently linked to agents such as 
barbiturates, cephalosporins, NSAIDs, estrogens, 
phenothiazines, progestogens, protease inhibitors, 
sulphonamides, sulphonylurea derivatives, and 
tetracyclines—may give rise to erythema multiforme, and it 
may be clinically impossible to distinguish drug-induced 
erythema multiforme from disease due to other causes.[22]. 
The distinction of severe erythema multiforme from toxic 
epidermal necrolysis is quite unclear. 
H]. LUPOID REACTIONS: 
Systemic lupus erythematosus (SLE) may be induced by a 
wide variety of different drugs. Indeed, over 70 agents have 
been implicated in causing drug-induced lupus.[23]. The 
most commonly implicated agents of drug-induced SLE are 
procainamide and hydralazine, although drugs less commonly 
associated include chlorpromazine, isoniazid, methyldopa, 
penicillamine, and quinine, as well as whole groups of drugs 
such as anticonvulsants, beta-blockers, sulphonamides,[24]. 
and others. 
 
ORAL MALODOR: 
Oral Malodor or Halitosis is offensive breath resulting from 
poor oral hygiene, dental or oral infections, ingestion of 
certain foods, use of tobacco, and some systemic disease and 
medications. Drugs causing xerostomia, may indirectly cause 
or aggrave this problem, but other drugs, such as isosorbide 
dinitrate, dimethyl sulphoxide, or disulfiram, can be directly 
responsible for malodor.[17]. Drugs causing oral malodor are 
shown in Table 5. 
Table 5: Drugs causing Oral Malodor.[37,47]. 
  Chloral hydrate 
  Cytotoxic drugs 
  Dimethyl sulphoxide 
  Disulfiram 
  Nitrates and nitrites 
  Succimer 
 
WHITE LESIONS: 
  A].  LICHENOID ERUPTIONS: 
Lichen planus is a chronic systemic disease of the established 
immune mediated pathogenesis. Oral lichen planus is usually 
a persistent disorder and may persist for many years despite 
several treatment strategies. Some drugs can induce oral 
disorders resembling lichen planus and are said to be oral 
lichenoid drug reactions. Oral lichenoid reactions are 
uncommon and these reactions disappear after drug 
withdrawal.[25,26]. A characteristic white lace pattern may 
be seen.  The drugs now most commonly implicated in 
lichenoid reactions are the non-steroidal anti-inflammatory 
drugs and the angiotensin-converting enzyme inhibitors. 
Lichenoid reactions also may follow the use of HIV protease 
inhibitors , antihypertensive agents, antimalarials, 
phenothiazines, sulphonamides, tetracyclines, thiazide 
diuretics,[27] and many others. Drugs with potential to cause 
oral lichenoid eruptions are listed in Table 6. 
 
Table 6: Drugs Causing Oral Lichenoid Reactions. [17,37,48]. 
  ACE inhibitors 
  Allopurinol 
  Amiphenazole 
  Angiotensin converting 
enzyme inhibitors 
  Antimalarials 
  Arsenical compounds 
  Barbiturates 
  BCG vaccine 
  Carbamazepine 
  Carbimazole 
  Chloroquine 
  Chlorpropamide 
  Cholera vaccine 
  Clofibrate 
  Colchicine 
  Dapsone 
  Dipyridamole 
  Ethionamide 
  Flunarizine 
  Gaunoclor 
  Gold compounds 
  Griseofulvin 
  Hepatitis B vaccine 
 
  Hydroxychloroquine 
  Ketoconazole 
  Lithium carbonate 
  Lorazepam 
  Mepacrine 
  Mercury (Amalgam) 
  Metformin  
  Methyldopa 
  Metronidazole 
  NSAIDs 
  Penicillins 
  Phenytoin 
  Piroxicam  
  Propranolol 
  Quinidine 
  Rifampicin 
  Streptomycin 
  Sulphonamides 
  Tetracyclines 
  Thalidomide 
  Thiazides 
  Tolbutamide 
  Triprolidine 
 
 B].ORAL CANDIDIASIS: 
Candidiasis is the most common opportunistic infection seen 
in dental practices. Patients usually present with creamy, 
white plaques on the tongue and buccal mucosa, it when 
scraped leave a red, painful ulcerated surface exposed. 
Pseudomembranous candidosis arises secondary to therapy 
with broad-spectrum antibiotics, corticosteroids - systemic 
and inhaler preparations, and other immunosuppressive 
regimens (e.g., ciclosporin) and cytotoxic therapy.[28]. 
 C]. BLACK HAIRY TONGUE (Lingua villosa nigra) 
This condition is presented with an elongation of the filliform 
papillae of the tongue to form hair like over growth which 
becomes stained brown or black due to the proliferation of 
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seen with the administration of oral antibiotics, poor oral 
hygiene and excessive smoking in adults.[17]. Drugs causing 
black hairy tongue are listed in Table 7. 
 
 
Table 7: Drugs and Chemicals Causing Black Hairy Tongue. [17,37,49]. 
  Amitriptyline 
  Benztropine 
  Cephalosporines 
  Chloramphenicol 
  Clarithromycin 
  Clomipramine 
  Clonazepam 
  Corticosteroids 
  Desipramine 
  Fluoxetine 
  Griseofulvin 
  Imipramine 
  Lansoprazole 
  Methyldopa 
 
  Maprotilline 
  Nortriptyline 
  Olanzapine 
  Penicillins  
  Sodium perborate 
  Sodium peroxide 
  Streptomycin 
  Sulfonamides 
  Tobacco 
  Tetracycline 
  Thiothixene 
  Tranylcypromine 
  Vegetable dyes 
 
 
Table 8: Drugs Causing Gingival Hyperplasia. [4,17,37]. 
  Amlodipine 
  Bepridil 
  Cannabis 
  Cotrimoxazole 
  Cyclosporine 
  Diltiazem 
  Erythromycin 
  Ethosuximide 
  Ethotoin 
  Felodipine 
  Flunarizine 
  Interferon alpha 
  Ketoconazole 
  Lamotrigene 
 
  Lithium 
  Mephenytoin 
  Nifedipine 
  Nitrendipine 
  Oral contraceptives 
  Phenytoin 
  Phenobarbitone 
  Primidone 
  Sertraline 
  Sodium valproate 
  Topiramate 
  Verapamil 
  Vigabatrin 
 
TASTE ALTERATIONS: 
Individuals taking any variety of medications may present 
with subjective complaints of taste changes. Many classes of 
drus are associated with taste alteration, which manifests as 
hypoguesia (decreased taste), dysguesia (distortion of the 
correct taste), paraguesia (bad taste), aguesia (no taste).[29]. 
ACE inhibitors, anti-thyroids, beta-lactam antibiotics, 
biguanides, chlorhexidine, opiates, and protease inhibitors are 
particularly implicated. Up to 4% of patients treated with 
ACE inhibitors may have dysgeusia, although this adverse 
effect is self-limiting and reversible within a few months, 
even with continued therapy. Newer therapies—such as the 
anti-HIV protease inhibitors, therapy with tripotassium 
dicitrato bismuthate chelate, clarithromycin, and lansoprazole 
therapy for H. pylori infection, terbinafine, intravenous 
pentamidine , and isotretinoin.[30]. Reduction of the 
offending drug can improve the taste. Drugs with potential to 
cause aguesia and dysguesia are listed in Table 9 and 10. 
 
Table 9: Drugs Causing  Ageusia. [17,37,50,51]. 
                  Acarbose                   Fluvoxamine
                  Acetazolamide                   Indomethacin
                  Amitriptyline                   isotretinoin
                  Angiotensin II 
receptor antagonist                   Levodopa
                  Asprin                   Methimazole
                  Atrovastatin                   Penicilliamine 
                  Captopril                   Pentamidine
                  Ceftirizine                   Phenytoin
                  Cisplatin                   Propantheline
                  Clidinium                   Propylthiouracil
                  Clopidogrel                    Rifabutin
                  Cocaine                   Ritonavir
                  Diazoxide                   Rivastigmine
                  Dicyclomine                   Spironolactone
                  Enalapril                   Sulfadoxine
                  Etridonate                  Terbinafine   
topiramate
                  fluoxetine                   Venlafaxine
 
 
 
Table 10: Drugs Causing Dysgeusia. [17,37,52,53]. 
  ACE inhibitors 
  Acetaminophen 
  Alendronate 
  Allopurinol 
  Alprazolam 
  Amiloride 
  Amiodarone 
  Amlodipine 
  Asprin 
  Auranofin 
  Baclofen 
  Beclomethazone 
  Bleomycin 
  Busulfan 
  Calcitonin 
  Cimetidine 
  Ciprofloxacin 
  Clomipramine 
  Cotrimazole 
  Dantrolene 
  Fentanyl  
  Fluvastatin 
  Gadobenate 
  Gancyclovir 
  Glyburide 
  Gold compounds 
  Imipramine 
  Indinavir 
  Ketorolac 
  Levodopa 
 
  Lignocaine 
  Maprotilline 
  Methocarbamol 
  Metoprolol 
  Minoxidil 
  Mupirocin 
  Nedocromil 
  Nitroglycerine  
  Nylidrin 
  omidazole 
  Palifermin 
  Phenytoin  
  Pilocarpine 
  Propafenone 
  Protirelin 
  Quinidine 
  Ranitidine 
  Ribavirin 
  Risperidone 
  Selegiline 
  Sunitinib 
  Tacrine 
  Tamoxifen 
  Tegafur 
  Terbinafine 
  Tiagabin 
  Tolazamide 
  Tramadol 
  Ursodiol 
  Vinblastine 
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93MUCOSAL PIGMENTATION: 
Oral discoloration may be superficial due to extrinsic or deep 
due to intrinsic causes. 
Extrinsic discoloration is rarely of consequence and is usually 
caused by habits that include the following: 
‐  Use of tobacco or betel nut 
‐  Consumption of colored foods or beverages 
‐  Use of drugs (such as chlorhexidine, iron salts, cocaine, 
minocycline, bismuth subsalicylate and lansoprazole) 
The primary causes of intrinsic mucosal hyperpigmentation 
include: [31] 
‐  Amalgam or other tattoo 
‐  Nevus 
‐  Melanotic macule 
‐  Peutz-jegher’s syndrome 
‐  Racial pigmentation 
‐  Drugs such as antimalarials and oral contraceptives 
‐  Addison’s disease  
‐  Pregnancy 
Pigmented lesions of the tongue( dark macular patches) are 
reported to occur in heroin addicts who inhale the 
smoke.[32]. Drugs causing oral mucosal pigmentation along 
with the color and site are listed in Table 11. 
 
 
TEETH DISCOLORATION: 
Tetracycline and minocycline are antimicrobial agents 
causing the teeth to stain. Systemic ingestion of tetracycline 
causes irreversible staining in developing teeth and bones. 
The cervical third is most affected and staining is directly 
proportional to the age at drug exposure, dosage and duration 
of therapy.[33].Minocycline, unlike tetracycline staining 
occurs after the teeth are fully developed and erupted. 
Minocycline penetrates easily into both soft and calcified 
tissues. Pigmentation is produced by incorporation of the 
drug from the pulp into the dentin and enamel. Oxidation 
from the saliva and gingival crevicular fluid produces a blue-
gray staining in the middle and incisal thirds of the teeth. 
Minocycline staining is irreversible.[34,35]. Metals, such as 
lead or mercury, or drugs that contain metals, such as gold 
salts, produce pigmentation changes along the gingival 
margin. These colour changes may resolve following 
discontinuation of the drug, but may be permanent.[36]. 
Drugs causing teeth discoloration along with the color are 
listed in Table 12 
Table 12: Drugs And Chemicals Causing Tooth Discoloration. [17,43]
Drugs/Chemicals Color 
Betel leaves (areca)  Red to black 
Cadmium Yellow  ring 
Cayenne Black 
Chlorhexidine Yellow-brown 
Chlortetracycline Gray-brown 
Ciprofloxacin Green 
Co-amoxiclav  Yellow or gray brown 
Copper salts  Green 
Doxycyclin Yellow 
Essential oils  Yellow brown 
Fluoride White  brown 
Iron salts (liquid)  Black 
Isoproterenol Chalky  white 
Minocycline Gray  black 
Oxytetracycline Yellow 
Potassium permanganate  Violet to black 
Silver nitrate  Gray 
Tannins (coffee,Tea)  Brown 
Tetracycline Yellow 
Tobacco Yellow-brown 
Tooth paste with stannous fluoride  Black or green 
White wine  Black 
 
POSTMORTEM PINK-RED COLORATION:  
Tooth coloration of this type is due to hemolysis and 
exudation of hemoglobin to the dental pulp which is 
enhanced in the presence of moisture and increased venous 
pressure. Specific conditions of death associated with this 
phenomenon include drowning, aspiration, pneumonitis, and 
suffocation. Overdose with barbiturates, dichloralphenazon, 
and carbon monoxide also present with similar findings.[37]. 
 
SWELLINGS: 
 A] GINGIVAL HYPERPLASIA: 
Gingival Hyperplasia is a known side effect associated with 
the anticonvulsant phenytoin, the immunosuppressant 
Table 11: Drugs Causing Oral Mucosal Pigmentation.[17]. 
Drug/Chemical Colour  Site 
Amalgam Gray  Gingiva 
Aminopyrine Brown  Tongue 
Amodiaquine Blue-gray/black  Palate 
Arsenic Brown  Tongue 
Asprin White  Mucosa 
Bismuth  Blue-gray/blue-
black  Gum lines/tongue 
Busulfan Brown  Mucosa 
Chlorhexidine White/brown  Tongue 
Chloroquine Blue-gray  Palate,gingiva,lip 
Copper salts  Blue-green  Gum lines 
Doxorubicin Dark/Brown Mucosa/Tongue 
Gold Purple  Gingiva 
Heroin inhalation  Dark Macular 
Patch  Tongue 
Lansoprazole Yellow  Tongue 
Lead Blue-gray/Blue  Gum  lines/Tongue 
Mepacrine Yellow  Mucosa 
Mercury  Blue-gray/Blue-
Black  Gum line/Mucosa 
Methyldopa Dark  Tongue 
Phenolphthalein Brown  Tongue 
Phenothiazines Blue-Gray  Mucosa 
Quinacrine Gray/Brown  Palate/Tongue 
Quinidine Blue-black  Palate 
Silver salts  Gray  Gingiva 
Thallium Blue-gray  Gumlines 
Tin Dark  Mucosa 
Tobacco  Hazy gray brown  Mucosa 
Vanadium Green  Tongue 
Zidovudine Dark 
Soft 
Palate,Gingiva,lips,ton
gue 
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94cyclosporine, and the calcium channel blockers used for 
hypertension and angina.  Drug induced gingival enlargement 
can be localized or generalized and varies with degree of 
severity. Enlargement typically affects the labial tissues and 
begins in the interdental papillae. Severity is directly 
proportional to the patients oral hygiene. The enlarged 
gingiva appears fibrotic and the patient often develops an 
overlying inflammation, as hyperplastic tissues can be 
difficult to keep clean.[38,39]. Drugs which have the 
potential to cause gingival hyperplasia are listed in Table 8. 
B] MUCOSAL SWELLING: 
Drugs are the most common cause of urticarial reactions in 
adults affecting approximately 15-20% of young adults. 
Urticaria is a vascular reaction in the superficial layers of the 
skin, characterized by local edema and increased capillary 
permeability with wheals (hives), often accompanied by 
severe itching. When this swelling occurs in either the 
subcutaneous or submucosal tissues, the condition is known 
as angioedema. Drugs like penicillins, local anesthetic agents, 
cephalosporin derivatives, angiotensin-converting enzyme 
inhibitors, aspirin, and barbiturates—may give rise to angio-
edema.[40]. Hypersensitivity to latex is an increasing 
problem in oral health care and may cause rapid-onset angio-
edema in susceptible patients. 
Topical anaesthetic agents, dental local anaesthetics, and 
drugs are associated with type-I hypersensitivity reactions. 
This type of allergic reaction has a rapid onset, with oral 
lesions developing, in and around the oral cavity, with 
urticarial swelling or angioedema of the lips, tongue and oral 
mucosa.[41]. 
     
CONCLUSION: 
Numerous Drugs have the capability to cause adverse effects 
in the oral cavity. Drugs have the potential to cause 
conditions such as salivary gland disease, oral ulceration, 
taste alterations, discoloration of teeth, mucosal 
pigmentation, white lesions, swellings and oral malodor. 
These side effects interfere with the patient function and 
increase risk of infection, pain and possible tooth loss. It has 
been reported that the most common side effects of drugs are 
xerostomia, Altered taste and stomatitis.[42]. It is imperative 
that health professionals understand the complications that 
medications can have on the oral health of their patients. In 
order to properly diagnose and treat patients, a complete 
medical history including prescription medications, over the 
counter drugs and dietary supplements must be recorded 
which will enable the healthcare team to identify the 
causative agents. 
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